Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0624 CHF | -1.89% | -2.19% | +52.20% |
01/05 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
17/04 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+52.20% | 4.75M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-16.14% | 31.87B | |
+53.42% | 24.52B | |
-14.73% | 15.68B | |
-6.52% | 12.34B | |
-39.65% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Spexis Secures Debt-restructuring Moratorium From Swiss Court